All lobbying filings

DB3, LLC (FKA the Daschle Group)

DB3, LLC (FKA the Daschle Group) filed a Q4 report for Otsuka America Pharmaceutical, Inc. on January 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Otsuka America Pharmaceutical, Inc. · Pharmaceutical manufacturer

As filed: DB3, LLC (FKA THE DASCHLE GROUP) for OTSUKA AMERICA PHARMACEUTICAL, INC.

All filings by DB3, LLC (FKA the Daschle Group) · Everything Otsuka America Pharmaceutical, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Research, development, and reimbursement of novel serotonergic agonists for mental health conditions

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.